Title: Note 1 – Basis of presentation
Accounting Policies: NOTE 1 – BASIS OF PRESENTATION - The accompanying schedule of expenditures of Federal awards (the Schedule) includes the Federal grant activity of American Thoracic Society, Inc. under programs of the Federal government for the year ended December 31, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of American Thoracic Society, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of American Thoracic Society, Inc. NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICES - Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. NOTE 3 – INDIRECT COST RATE - American Thoracic Society, Inc. elected to use the 10 percent de minimis cost rate as allowed under the Uniform Guidance.
De Minimis Rate Used: Y
Rate Explanation: American Thoracic Society, Inc. elected to use the 10 percent de minimis cost rate as allowed under the Uniform Guidance.
The accompanying schedule of expenditures of Federal awards (the Schedule) includes the Federal grant activity of American Thoracic Society, Inc. under programs of the Federal government for the year ended December 31, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of American Thoracic Society, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of American Thoracic Society, Inc.
Title: NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICES
Accounting Policies: NOTE 1 – BASIS OF PRESENTATION - The accompanying schedule of expenditures of Federal awards (the Schedule) includes the Federal grant activity of American Thoracic Society, Inc. under programs of the Federal government for the year ended December 31, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of American Thoracic Society, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of American Thoracic Society, Inc. NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICES - Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. NOTE 3 – INDIRECT COST RATE - American Thoracic Society, Inc. elected to use the 10 percent de minimis cost rate as allowed under the Uniform Guidance.
De Minimis Rate Used: Y
Rate Explanation: American Thoracic Society, Inc. elected to use the 10 percent de minimis cost rate as allowed under the Uniform Guidance.
Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement.
Title: NOTE 3 – INDIRECT COST RATE
Accounting Policies: NOTE 1 – BASIS OF PRESENTATION - The accompanying schedule of expenditures of Federal awards (the Schedule) includes the Federal grant activity of American Thoracic Society, Inc. under programs of the Federal government for the year ended December 31, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of American Thoracic Society, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of American Thoracic Society, Inc. NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICES - Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. NOTE 3 – INDIRECT COST RATE - American Thoracic Society, Inc. elected to use the 10 percent de minimis cost rate as allowed under the Uniform Guidance.
De Minimis Rate Used: Y
Rate Explanation: American Thoracic Society, Inc. elected to use the 10 percent de minimis cost rate as allowed under the Uniform Guidance.
American Thoracic Society, Inc. elected to use the 10 percent de minimis cost rate as allowed under the Uniform Guidance.
Title: NOTE 4 – RECONCILIATION
Accounting Policies: NOTE 1 – BASIS OF PRESENTATION - The accompanying schedule of expenditures of Federal awards (the Schedule) includes the Federal grant activity of American Thoracic Society, Inc. under programs of the Federal government for the year ended December 31, 2023. The information in the Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of American Thoracic Society, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of American Thoracic Society, Inc. NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICES - Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. NOTE 3 – INDIRECT COST RATE - American Thoracic Society, Inc. elected to use the 10 percent de minimis cost rate as allowed under the Uniform Guidance.
De Minimis Rate Used: Y
Rate Explanation: American Thoracic Society, Inc. elected to use the 10 percent de minimis cost rate as allowed under the Uniform Guidance.
The table below summarizes a reconciliation between the revenue reported on the financial statements for the year ended December 31, 2023 and the Federal grant expenditures reported on the schedule of expenditures of Federal awards for the year ended December 31, 2023: (See the Notes to the SEFA for chart/table)